timolol has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Millá Griñó, E; Muniesa Royo, MJ; Pazos López, M | 1 |
| Rodríguez Bandera, AL; Sebaratnam, DF; Wargon, O; Wong, LF | 1 |
1 review(s) available for timolol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Infantile hemangioma. Part 2: Management.
Topics: Adrenergic beta-Antagonists; COVID-19; Hemangioma, Capillary; Humans; Infant; Nevus; Pandemics; Propranolol; SARS-CoV-2; Skin Neoplasms; Timolol; Treatment Outcome | 2021 |
1 other study(ies) available for timolol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
[Therapeutic conflict in patients with COVID-19 and glaucoma].
Topics: Adrenergic beta-Antagonists; Antimalarials; Betacoronavirus; Bioaccumulation; Bradycardia; Coronavirus Infections; COVID-19; Glaucoma, Open-Angle; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Timolol | 2020 |